Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor

KL Hanson, M Luciana - Journal of Clinical and Experimental …, 2010 - Taylor & Francis

Author(s): Karen Hanson , Monica Luciana

Focus: MDMA


Background: MDMA (3, 4-methylenedioxymethamphetamine;“Ecstasy”) is an amphetamine derivative with mild hallucinogenic and stimulant qualities. MDMA leads to serotonin (5-hydroxytryptamine; 5-HT) neurotoxicity and has been linked to cognitive impairments. It …

Last updated: Jul 27, 2020